Mealey's (October 14, 2022, 11:03 AM EDT) -- WASHINGTON, D.C. — In an order issued Oct. 13, the U.S. Supreme Court vacated its recent stay of a mandate by the Federal Circuit U.S. Court of Appeals that would clear a path for the launch of generic Gilenya, a patented treatment for multiple sclerosis (MS)....